SLC5A1 and cancer: The interaction between EGFR and SGLT1 may represent a novel mechanism of adaptation by cancer cells to meet energy demand for cellular growth and suggests that EGFR contributes to increased cell survival and metastasis independent of the EGFR signalling pathway.